Vanguard Group’s Sight Sciences SGHT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$15.5M Buy
1,948,647
+41,951
+2% +$268K ﹤0.01% 2740
2025
Q3
$6.56M Buy
1,906,696
+102,609
+6% +$382K ﹤0.01% 3183
2025
Q2
$7.45M Buy
1,804,087
+106,968
+6% +$357K ﹤0.01% 3059
2025
Q1
$4.07M Buy
1,697,119
+63,190
+4% +$178K ﹤0.01% 3249
2024
Q4
$5.95M Sell
1,633,929
-56,818
-3% -$259K ﹤0.01% 3200
2024
Q3
$10.7M Buy
1,690,747
+44,200
+3% +$297K ﹤0.01% 2916
2024
Q2
$11M Buy
1,646,547
+90,097
+6% +$533K ﹤0.01% 2860
2024
Q1
$8.22M Buy
1,556,450
+81,768
+6% +$384K ﹤0.01% 3071
2023
Q4
$7.61M Buy
1,474,682
+64,721
+5% +$200K ﹤0.01% 3098
2023
Q3
$4.75M Buy
1,409,961
+3,447
+0.2% +$22.6K ﹤0.01% 3272
2023
Q2
$11.6M Buy
1,406,514
+15,339
+1% +$138K ﹤0.01% 2854
2023
Q1
$12.2M Buy
1,391,175
+22,508
+2% +$250K ﹤0.01% 2833
2022
Q4
$16.7M Buy
1,368,667
+3,457
+0.3% +$32.9K ﹤0.01% 2715
2022
Q3
$8.67M Buy
1,365,210
+234,716
+21% +$1.98M ﹤0.01% 3020
2022
Q2
$10.2M Buy
1,130,494
+47,769
+4% +$420K ﹤0.01% 2980
2022
Q1
$12.5M Buy
1,082,725
+521,412
+93% +$8.03M ﹤0.01% 3032
2021
Q4
$9.86M Sell
561,313
-770,617
-58% -$16.9M ﹤0.01% 3211
2021
Q3
$30.2M Buy
+1,331,930
New +$43.8M ﹤0.01% 2639

Other funds holding SGHT

Vanguard Group's SGHT Position: Q4 2025 in Review

Vanguard Group increased its Sight Sciences (SGHT) stake by 2.2% in Q4 2025, buying an estimated $268K and bringing the position to 1,948,647 shares worth $15.5M. The position accounts for ﹤0.01% of the portfolio, ranked #2740.

Vanguard Group first reported a position in SGHT in Q3 2021 and has held it in 18 quarters since. The position peaked at $30.2M in Q3 2021. 111 funds tracked by Wall St. Rank hold SGHT as of Q4 2025.

  • Vanguard Group held 1,948,647 shares of Sight Sciences worth $15.5M as of Q4 2025.
  • Vanguard Group bought 41,951 Sight Sciences shares in Q4 2025, an estimated $268K.
  • Sight Sciences made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #2740 holding.
  • Vanguard Group first reported a position in Sight Sciences in Q3 2021 and has held it in 18 quarters since.
  • Vanguard Group's Sight Sciences position peaked at $30.2M in Q3 2021.
  • 111 funds tracked by Wall St. Rank held Sight Sciences as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.